INS and type 1 diabetes mellitus: Vanadium compounds are nonspecific phosphotyrosine phosphatase inhibitors that have proven insulin-mimetic and/or insulin enhancing activity either in vitro or in vivo, countering hyperglycemia observed in T1DM human subjects and also maintaining glucose homeostasis in T2DM subjects [74,75].